DR. PAUL AISEN
ADVISOR
Dr. Aisen is a professor in the Department of Neurosciences at the University of California, San Diego, School of Medicine. He is also director of the Alzheimer’s Disease Cooperative Study (ADCS). He was one of the first Alzheimer’s disease clinical trialists in the U.S. and was an investigator in the pivotal FDA registration studies for Namenda®. He received his M.D. from Columbia University.


DR. ROBERT M. MORIARTY
ADVISOR
Dr. Robert M. Moriarty is a consultant of OrgSyn Laboratory, Inc. Dr. Moriarty worked as a research chemist at Merck from 1955-57. He founded Steroids Limited in 1981, which became SynQuest Limited and was acquired by United Therapeutics in 2000. Dr. Moriarty has authored over 200 articles on various topics in synthetic and mechanistic organic synthesis. Dr. Moriarty is a recipient of several prestigious awards and grants.


DR. DINESH PATEL
ADVISOR
Dr. Patel is the Chairman of the Board and Co-founder of Xel Herbaceuticals Inc. Dr. Patel has served fourteen years as Co-founder, Chairman of the Board of Directors, President & CEO, of TheraTech, Inc., a Salt Lake City based company that has been a pioneer in the development and manufacture of innovative drug delivery products. Under Dr. Patel's guidance, TheraTech established strategic alliances with major pharmaceutical companies, including Eli Lilly, Pfizer, Procter & Gamble, Roche, SmithKline Beecham, and Wyeth-Ayerst. Dr. Patel directed the construction of a state-of-the-art manufacturing facility and oversaw the company's R&D efforts through the manufacture of its currently marketed transdermal products (transdermal testosterone and estrogen hormone-replacement therapy patches). Dr. Patel has been the recipient of numerous awards.

DR. DONALD F. WEAVER
ADVISOR
Dr. Weaver is currently Canada Research Chair in Neuroscience/Chemistry, Professor of the Department of Medicine (Neurology), Professor of the Department of Chemistry and Professor of the School of Biomedical Engineering at Dalhousie University in Halifax, Nova Scotia, Canada. With experience that spans academic and commercial interests, he has published hundreds of articles, is a prolific inventor with over 70 patents to his name and is the recipient of many awards and honors. Dr. Weaver co-founded three biotechnology companies, including Neurochem, Inc., and is a fellow of the Canadian Institute of Chemistry (FCIC), a fellow of the Royal College of Physicians and Surgeons of Canada (FRCIP) and a board-certified neurologist.